WCN25-136 IMPROVE KIDNEY CARE: PERSPECTIVES FROM PEOPLE WITH CKD AND RISK FACTORS FOR CKD ON ACCESS TO AND EXPERIENCE OF NEPHROLOGY SERVICES

WCN25-136 IMPROVE KIDNEY CARE: PERSPECTIVES FROM PEOPLE WITH CKD AND RISK FACTORS FOR CKD ON ACCESS TO AND EXPERIENCE OF NEPHROLOGY SERVICES

Saved in:

Bibliographic Details
Main Authors:	Rebekah Grace Cheung Judge, Roseline Agyekum, Anjolaoluwa Awe, Muhammad Bojang, Kate Bramham, Nadine Fontaine Palmer, Stephanie Hanson, Imani Henry Bailey, Lina Johansson, Adam Kamenetzky, Ritika Haresh Karamchandani, Jordanna Nunes, Shone Surendran, Nupur Yogarajah
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924025336
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CKD Knowledge and CKD Report Card Use During a Nephrology Encounter: A Randomized Trial
by: Jillian Bowman, et al.
Published: (2025-05-01)

Anemia in Pregnancy With CKD
by: Margriet F.C. de Jong, et al.
Published: (2024-05-01)

Impact of CKD on Female Reproductive Hormones
by: Mahua Bhaduri, et al.
Published: (2025-07-01)

Inside CKD: Cost-Effectiveness of Multinational Screening for CKD
by: Navdeep Tangri, et al.
Published: (2025-04-01)

Targeting Gut Microbiome With Prebiotic in Patients With CKD: The TarGut-CKD Study
by: Michael B. Sohn, et al.
Published: (2024-03-01)

Holistic Impact of CKD: A Clinical, Economic, and Environmental Analysis by IMPACT CKD
by: Naveen Rao, et al.
Published: (2025-07-01)

Low Energy Diets for Obesity and CKD (SLOW-CKD Randomized Feasibility Study)
by: Marguerite M. Conley, et al.
Published: (2025-07-01)

The Role of Sodium-Glucose Cotransporter-2 Inhibitors in the Treatment Paradigm of CKD in Africa: An African Association of Nephrology Panel Position Paper
by: Faical Jarraya, et al.
Published: (2024-03-01)

The Promise of Dotinurad for Hyperuricemia in CKD
by: Amy S. Li, et al.
Published: (2025-06-01)

Statin Use and the Progression of Coronary Artery Calcification in CKD: Findings From the KNOW-CKD Study
by: Jihyun Yang, et al.
Published: (2024-10-01)

Optimizing osteoporosis management in CKD patients
by: Yong Wang, et al.
Published: (2025-04-01)

New Obesity Guidelines and Implications for CKD
by: Tilman B. Drueke, et al.
Published: (2025-05-01)

Updates on New Therapies for Patients with CKD
by: Tushar Tarun, et al.
Published: (2024-01-01)

Barriers to Care: New Medications and CKD
by: Dana Kim, et al.
Published: (2024-03-01)

Framework of Guidelines for Management of CKD in Asia
by: Carol Pollock, et al.
Published: (2024-04-01)

Safety of Drugs in Breastfeeding Women With CKD
by: Paula Parnizari, et al.
Published: (2025-07-01)

Association of Phenylacetylglutamine and Cognitive Impairment in CKD
by: Hélène Levassort, et al.
Published: (2025-08-01)

WCN25-1136 FRAILTY IN CKD
by: Beatriz Mendes, et al.
Published: (2025-02-01)

Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation
by: Soon Kyu Lee, et al.
Published: (2025-01-01)

The Impact of Anaemia on Outcomes, Admissions, and Costs in Patients with Chronic Kidney Disease in Two Public Nephrology Practices in Queensland: A CKD.QLD Registry Study
by: Jianzhen Zhang, et al.
Published: (2023-01-01)

Re: Activated Omentum Slows Progression of CKD
by: Fehmi Narter
Published: (2018-12-01)

Mitochondrial Dysfunction: The Nexus of Aging, Dyslipidemia, and CKD
by: Yu-Hsiang Lin, et al.
Published: (2025-03-01)

CKD: A Guide to Higher Fiber Foods
by: Wendy J. Dahl, et al.
Published: (2018-01-01)

Risk Stratification for CKD Progression in Primary Care
by: Clyson Mutatiri, et al.
Published: (2025-05-01)

CKD: A Guide to Higher Fiber Foods
by: Wendy J. Dahl, et al.
Published: (2018-01-01)

Research on CKD-MBD from the Prospective of TCM
by: WANG Xiao-qin, et al.
Published: (2020-01-01)

In response to optimizing osteoporosis management in CKD patients
by: Jordi Bover, et al.
Published: (2025-04-01)

CKD: A Guide to Higher Fiber Foods
by: Wendy J. Dahl, et al.
Published: (2018-01-01)

CKD of Unknown Etiology: Is Taiwan Another Hotspot?
by: Isabelle Dominique Tomacruz Amante, et al.
Published: (2024-01-01)

The Important Role of Sleep in CKD Prevention and Progression
by: Ginger Chu, et al.
Published: (2025-06-01)

Clinical Significance of FGF-23 in Patients with CKD
by: Domenico Russo, et al.
Published: (2011-01-01)

Longitudinal Lipid Trajectories and Progression of CKD in Children
by: Uwe Querfeld, et al.
Published: (2025-05-01)

Dotinurad Treatment for Patients With Hyperuricemia Complicating CKD
by: Katsuyuki Tanabe, et al.
Published: (2025-06-01)

Risk Factors for Progression of CKD with and without Diabetes
by: Xiaohong Zhang, et al.
Published: (2022-01-01)

Evaluation of CRP SNV rs2808630 and acute proinflammatory biomarkers in patients with CKD and PLHIV with CKD: a case-control study
by: Andrea Torres-Rojas, et al.
Published: (2025-05-01)

Tacrolimus levels and variability in CKD and ESRD risk post-liver transplant: Letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
by: Rui Shi, et al.
Published: (2025-04-01)

WCN25-3917 CKD IN HIGH-ENDEMIC REGIONS: COMMUNITY INSIGHTS FROM SELF-REPORTED, NEWLY DIAGNOSED, AND NON-CKD RESIDENTS
by: Kavita Yadav, et al.
Published: (2025-02-01)

Correspondence to editorial on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
by: Soon Kyu Lee, et al.
Published: (2025-04-01)

Characterization of Monogenic Kidney Disease in Older Patients With CKD
by: Elhussein A.E. Elhassan, et al.
Published: (2025-07-01)

Prevalence of dysmagnesemia among CKD patients in North India
by: Shailata Prisi, et al.
Published: (2025-03-01)